![James R. Englund](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profilo
James R.
Englund worked as a Controller at Auxilium Pharmaceuticals LLC from 2005 to 2015.
He also worked as a Vice President & Controller at Strongbridge Biopharma Plc.
He obtained an undergraduate degree from Rockford University.
Precedenti posizioni note di James R. Englund
Società | Posizione | Fine |
---|---|---|
AUXILIUM PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01/04/2015 |
STRONGBRIDGE BIOPHARMA | Comptroller/Controller/Auditor | - |
Formazione di James R. Englund
Rockford University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
Auxilium Pharmaceuticals LLC
![]() Auxilium Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Auxilium Pharmaceuticals LLC develops and markets pharmaceutical products. It specializes in men's healthcare area and has product portfolio and pipeline in orthopedics, dermatology and other therapeutic areas. The firm products include edex, Osbon, ErecAid, STENDRA, TESTOPEL, XIAFLEX and Testim. The company was founded by Gerri A. Henwood and Jane Holmes Hollingsworth in 1999 and is headquartered in Chesterbrook, PA. | Health Technology |
Strongbridge Biopharma Plc
![]() Strongbridge Biopharma Plc Pharmaceuticals: MajorHealth Technology Strongbridge Biopharma Plc operates as a commercial-stage biopharmaceutical company, which focuses on the development and commercialization of therapies for rare diseases. Its pipeline is comprised of Keveyis, Macrilen, Recorlev, and Veldoreotide. The company was founded in 1996 and is headquartered in Trevose, PA. | Health Technology |
- Borsa valori
- Insiders
- James R. Englund